November 12, 2015
A Pennsylvania federal judge on Tuesday again dismissed a proposed class action alleging defunct biotechnology firm Genaera Corp. shortchanged shareholders by undervaluing company assets sold through a liquidating trust, finding the majority of the revived claims don't show company directors breached duties owed to investors.
December 09, 2014
The Third Circuit on Monday stood behind its decision to revive a class action alleging that biotech company Genaera Corp. jettisoned assets at "fire sale" prices, despite claims that the litigation was time-barred and ran afoul of basic pleading standards.
August 13, 2013
A Pennsylvania federal judge ruled Monday that a two-year statute of limitations barred a putative class action alleging defunct biotechnology firm Genaera Corp. shortchanged shareholders by undervaluing company assets sold through a liquidating trust.